Dumbing Down Society: Foods, Beverages and Meds

Email Print
FacebookTwitterShare

 

 
 

Is there
a deliberate effort by the government to dumb down the masses? The
statement is hard to prove but there exists a great amount of data
proving that the ruling elite not only tolerates, but effectively
introduces policies that have a detrimental effect on the physical
and mental health of the population. This series of articles looks
at the many ways the modern man is being dumbed down. Part I looks
at the poisons found in everyday foods, beverages and medications.

The theme of
dumbing-down and dehumanizing the masses are often discussed in
articles on The Vigilant Citizen. The presence of those concepts
in popular culture are, however, only the outward and symbolic expression
of the profound transformation happening in our society. Scientific
data has been proving for years that governments around the world
are tolerating the selling of many products which have a direct
and negative effect on cognitive and physical health. As we will
see in this article many everyday products cause brain damage, impaired
judgment and even a lower IQ.

Is a dumber
population something that is desired by the elite? Hitler once said
“How fortunate for the leaders that men do not think.”
An educated population knows its rights, understands the issues
and takes action when it does not approve of what is going on. Judging
by the incredible amount of data available on the subject, it seems
that the elite want the exact opposite: an unhealthy, frightened,
confused and sedated population. We will look at the effects of
medication, pesticides, fluoride and aspartame on the human body
and how those products are being pushed by people from inside the
power structure.

Prescription
Drug Abuse

America has
witnessed during the last decades a staggering rise of drugs being
prescribed to treat all kinds of problems. Children are particularly
affected by this phenomenon. Since the 1990?s, an ever-rising proportion
of American children are being diagnosed with “illnesses”
such as Attention Deficit Disorder (ADD) and are prescribed mind-altering
drugs, such as Ritalin.

The DEA
has become alarmed by the tremendous increase in the prescribing
of these drugs in recent years. Since 1990, prescriptions for methylphenidate
have increased by 500 percent, while prescriptions for amphetamine
for the same purpose have increased 400 percent. Now we see a situation
in which from seven to ten percent of the nation’s boys are
on these drugs at some point as well as a rising percentage of girls.
~ Source

Today, children
who show too much energy, character or strength are being willfully
sedated with powerful drugs which directly affect the way their
brains function. Are we going in the right direction here?

Even if ADD
is not a clearly defined and documented disorder – it causes
NO observable biological effects whatsoever – children are
still being diagnosed with the illness in great numbers. This raises
important ethical questions.

“Pediatricians
as well as ethicists have also voiced their concerns in usage of
these stimulants. In an article published in the New York Times,
they have questioned the appropriateness of medicating children
without a clear diagnosis in hopes that they do better in school.
They also asked whether the drugs should be given to adults failing
in their careers or are procrastinators. They question the worthy
of this method.

This concern
have also been voiced out in the January 2005 issue of
Pediatrics in which the large discrepancies between pediatricians’
practice patterns and the American Academy of Pediatrics (AAP) guidelines
for the assessment and treatment of children with attention-deficit/hyperactivity
disorder (ADHD) was bought forth. The article also stated that because
the medical community didn’t come to a consensus on how to
diagnose ADD/ADHD, they should not be making extensive decisions
as to how to treat individuals who have been diagnosed with the
disorder.”

The usage of
Ritalin at a young age breaks the psychological threshold people
maintain towards the usage of prescription pills, which makes those
children more likely to consume psychotropic drugs later in their
lives. We should not be surprised to witness a dramatic increase
of consumption of antidepressants in the years to come. The trend
is already beginning:

“In
its study, the U.S. Centers for Disease Control and Prevention looked
at 2.4 billion drugs prescribed in visits to doctors and hospitals
in 2005. Of those, 118 million were for antidepressants.

The use
of antidepressants and other psychotropic drugs – those that
affect brain chemistry – has skyrocketed over the last decade.
Adult use of antidepressants almost tripled between the periods
1988-1994 and 1999-2000. Between 1995 and 2002, the most recent
year for which statistics are available, the use of these drugs
rose 48 percent, the CDC reported.”
~ Elizabeth Cohen, CNN

The use of
prescription pills might be of a great help for specific and properly
diagnosed cases. The pharmaceutical industry however, which has
many “friends” in the highest levels of government, is
pushing for the widespread use of psychiatric drugs within the public.
Since 2002, a great number of pills claiming to fix all kinds of
mental conditions have been marketed to the public, but many of
those pills were approved for sale without proper research for side
effects. Even worse: the side effects might have been known but
hidden to the public. Below is a list of warnings issued on commonly
sold psychiatric drugs. Some of those side effects are actually
frightening as a pill should not be able to have that much power
over the human brain. Think about it: Some drugs are subject to
warnings because they can cause you to … commit suicide?

2004

March 22:
The Food and Drug Administration (FDA) warned that Prozac-like antidepressants
(called Selective Serotonin Reuptake Inhibitors or SSRIs) could
cause “anxiety, agitation, panic attacks, insomnia, irritability,
hostility, impulsivity, akathisia [severe restlessness], hypomania
[abnormal excitement] and mania [psychosis characterized by exalted
feelings, delusions of grandeur
].”

June:
The Therapeutic Goods Administration, the Australian equivalent
of the FDA, reported that the latest antipsychotic drugs could increase
the risk of diabetes.

June:
The FDA ordered that the packaging for the stimulant Adderall include
a warning about sudden cardiovascular deaths, especially in children
with underlying heart disease.

October
15
: The FDA ordered its strongest “black box” label
for antidepressants warning they could cause suicidal thoughts and
actions in under those under 18 years old.

October
21
: The New Zealand Medicines Adverse Reactions Committee recommended
that older and newer antidepressants not be administered to patients
less than 18 years of age because of the risk of suicide.

December
17
: The FDA required packaging for the “ADHD” drug,
Strattera, to advise that “Severe liver damage may progress
to liver failure resulting in death or the need for a liver transplant
in a small percentage of patients.”

2005

February
9
: Health Canada, the Canadian counterpart of the FDA, suspended
marketing of Adderall XR (Extended Release, given once a day) due
to reports of 20 sudden unexplained deaths (14 in children) and
12 strokes (2 in children).

April 11:
The FDA warned that antipsychotic drug use in elderly patients could
increase the risk of death.

June 28:
The FDA announced its intention to make labeling changes to Concerta
and other Ritalin products to include the side effects: “visual
hallucinations, suicidal ideation [ideas], psychotic behavior, as
well as aggression or violent behavior.”

June 30:
The FDA warned that the antidepressant Cymbalta could increase suicidal
thinking or behavior in pediatric patients taking it. It also warned
about the potential increased risk of suicidal behavior in adults
taking antidepressants.

August:
The Australian Therapeutic Goods Administration found a relationship
between antidepressants and suicidality, akathisia (severe restlessness),
agitation, nervousness and anxiety in adults. Similar symptoms could
occur during withdrawal from the drugs, it determined.

August
19
: The European Medicines Agency’s Committee for Medicinal
Products warned against child antidepressant use, stating that the
drugs caused suicide attempts and thoughts, aggression, hostility,
aggression, oppositional behavior and anger.

September
26
: The Agenzia Italiana del Farmaco (Italian Drug Agency, equivalent
to the FDA) warned against use of older (tricyclic) antidepressants
in people under 18 years old. It also determined the drugs were
associated with heart attacks in people of any age.

September
29
: The FDA ordered that labeling for the “ADHD” drug
Strattera include a boxed warning about the increased risk of suicidal
thinking in children and adolescents taking it.

October
17
: The FDA warned that the antidepressant Cymbalta could cause
liver damage.

October
24
: The FDA withdrew the stimulant Cylert from the market because
of the risk of liver toxicity and failure.

November:
The FDA warned that the antidepressant Effexor could cause homicidal
thoughts.

2006

February
9
: The FDA’s Drug Safety and Risk Management Advisory Committee
urged that the strongest “black box” warning be issued
for stimulants, because they may cause heart attacks, strokes and
sudden death.

February
20
: British authorities warned that Strattera was associated
with seizures and potentially lengthening period of the time between
heartbeats.

March 22:
An FDA advisory panel heard evidence of almost 1,000 reports of
kids experiencing psychosis or mania while taking stimulants.

May 3:
FDA adverse drug reaction reports linked antipsychotic drugs to
45 child deaths and 1,300 serious adverse reactions, such as convulsions
and low white blood cell count.

May 12:
The manufacturer of Paxil warned that the antidepressant increases
the risk of suicide in adults.

May 26:
Health Canada issued new warnings of rare heart risks for all drugs
prescribed for “ADHD,” including the risk of sudden death.

June 2:
An FDA study determined that the antipsychotic drug, Risperdal,
might cause pituitary tumors. The pituitary gland, at the base of
the brain, secretes hormones that promote growth, and regulates
body functions. Antipsychotics may increase prolactin, a hormone
in the pituitary gland, and this increase has been linked to cancer.
Risperdal was found to increase prolactin levels more frequently
than in other antipsychotics.

July 19:
The FDA said antidepressant packaging should carry warnings that
they may cause a fatal lung condition in newborns whose mothers
took SSRI antidepressants during pregnancy. Migraine sufferers also
need to be warned that combining migraine drugs with SSRIs could
result in a life-threatening condition called serotonin syndrome.

Food Poisoning

The modern
man ingests in his lifetime an incredible amount of chemicals, artificial
flavors and additives. Although there is growing awareness regarding
healthy eating, there is also a lot of misinformation and disinformation.

Read
the rest of the article

July
27, 2010

Email Print
FacebookTwitterShare